Related Experiment Video
Updated: Apr 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Tigecycline : a critical safety review
Quanhathai Kaewpoowat1, Luis Ostrosky-Zeichner
1University of Texas Health Science Center at Houston, Division of Infectious Diseases , 6431 Fannin Street, MSB 2.112, Houston, TX 77030 , USA +1 713 500 6733 ; +1 713 500 5495 ; quanhathai.kaewpoowat@uth.tmc.edu.
Tigecycline is a broad-spectrum antibiotic used for multidrug-resistant infections. However, concerns about its safety and efficacy necessitate prioritizing alternatives and careful patient monitoring when use is unavoidable.
Area of Science:
- Infectious Diseases
- Pharmacology
- Drug Safety
Background:
- Multidrug-resistant (MDR) infections pose a global health threat.
- Tigecycline is a broad-spectrum antibiotic frequently used against MDR organisms.
- Recent studies question the safety and efficacy of tigecycline.
Purpose of the Study:
- To review the safety profile of tigecycline.
- To analyze reported side effects and drug interactions.
- To inform appropriate clinical use of tigecycline.
Main Methods:
- Literature review of tigecycline safety data.
- Analysis of meta-analyses and clinical studies.
- Synthesis of information on adverse events and drug interactions.
Main Results:
- The safety and efficacy concerns surrounding tigecycline are highlighted.
- Increased mortality associated with tigecycline requires further investigation.
- Drug interactions and specific side effects are reviewed.
Conclusions:
- Alternative antibiotics should be preferred over tigecycline when possible.
- Vigilant monitoring for breakthrough infections and disease progression is crucial.
- Consideration of combination therapy may be necessary for optimal outcomes.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Inhibitors of Bacterial DNA Synthesis
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Teratogenicity
Clinical Significance of Antibiotic Resistance